Botulinum Toxin for the Treatment of Intractable Raynaud Phenomenon.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32948347.
- Also identified by DOI 10.1016/j.jhsa.2020.07.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Raynaud phenomenon (RP) is a condition causing vasospasm in the fingers and toes of patients that can have a significant negative impact on quality of life. This can lead to pain, ulceration, and possible loss of digits. Several pharmacological options are available for treatment. However, RP can often be refractory to traditional modalities, leaving surgery or injections as the next available options. This article provides a review and update on the use of botulinum toxin as an effective therapy for the treatment of RP refractory to medical management.
Medical subject headings
- Botulinum Toxins, Type A
- Neuromuscular Agents
- Raynaud Disease